1 / 6

Attention Deficit Hyperactivity Disorder Assessment Pipeline Review H1 2015

This report gives broad information on the medicinal change for Attention Deficit Hyperactivity Disorder (ADHD), complete with close examination at diverse stages, therapeutics assessment by drug target, instrument of action (MoA), course of association (RoA) and molecule sort, nearby latest overhauls, and highlighted news and press releases. It moreover reviews key players included in the remedial progression for Attention Deficit Hyperactivity Disorder (ADHD) and novel components on late-stage and halted assignments

RamonEMarshall01
Download Presentation

Attention Deficit Hyperactivity Disorder Assessment Pipeline Review H1 2015

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 By RnRMarketResearch.com Publisher Name : Global Markets Direct Date: 24-Jun-2015 No. of pages: 182 Single User License: US $2000 Browse more Reports on Neurology therapeutics at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics/neurology-therapeutics . ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  2. Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 This report gives broad information on the medicinal change for Attention Deficit Hyperactivity Disorder (ADHD), complete with close examination at diverse stages, therapeutics assessment by drug target, instrument of action (MoA), course of association (RoA) and molecule sort, nearby latest overhauls, and highlighted news and press releases. It moreover reviews key players included in the remedial progression for Attention Deficit Hyperactivity Disorder (ADHD) and novel components on late-stage and halted assignments. The report updates decision making limits and help to make capable counter philosophies to build high ground. It braces R&D pipelines by recognizing new targets and MOAs to make first-in-class and best-in-class things. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  3. Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 Companies Discussed/Mentioned in this Research: Alcobra Ltd, Amarantus Bioscience Holdings, Inc., Arbor Pharmaceuticals, LLC., Cerecor Inc., Collegium Pharmaceutical, Inc., Curemark, LLC, DURECT Corporation, Eli Lilly and Company, H. Lundbeck A/S, Hisamitsu Pharmaceutical Co., Inc., Integrative Research Laboratories Sweden AB, Intra-Cellular Therapies, Inc., KemPharm, Inc., Merck & Co., Inc., Mnemosyne Pharmaceuticals, Inc., Otsuka Holdings Co., Ltd. And more Drugs Profile Discussed in this Research : AR-08, BLI-1008, BNC-375, brexpiprazole, centanafadine IR, centanafadine SR, CM-4612, CTX-1301, CTX-1302, dasotraline, dextroamphetamine, dextroamphetamine MR, Drug for Attention Deficit Hyperactivity Disorder, edivoxetine, eltoprazine, etiguanfacine, guanfacine hydrochloride ER, HTL-1071, IRL-752, ITI-214, KP-415 CR, lisdexamfetaminedimesylate, Metadoxine ER, methylphenidate, methylphenidate hydrochloride, methylphenidate hydrochlorideand more ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  4. Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 Scope For Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 • The report provides a snapshot of the global therapeutic landscape of Attention Deficit Hyperactivity Disorder (ADHD) • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities • The report reviews key players involved in the therapeutics development for Attention Deficit Hyperactivity Disorder (ADHD) and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • A review of the Attention Deficit Hyperactivity Disorder (ADHD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  5. Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 Reasons to Buy: • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Develop strategic initiatives by understanding the focus areas of leading companies • Identify and understand important and diverse types of therapeutics under development for Attention Deficit Hyperactivity Disorder (ADHD) • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline • Devise corrective measures for pipeline projects by understanding Attention Deficit Hyperactivity Disorder (ADHD) pipeline depth and focus of Indication therapeutics ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

  6. Attention Deficit Hyperactivity Disorder - Pipeline Review, H1 2015 For more details contact Mr. Ritesh Tiwari :sales@rnrmarketresearch.com/ +18883915441 RnRMarkertResearch RnRMarketResearch.com, an online repository of market  research reports, offers in-depth analysis of over 5000 market segments. RnRMarket Research library has syndicated reports by leading market research  publishers across the globe. ©http://www.rnrmarketresearch.com/ ; sales@RnRMarketResearch.com +1 888 391 5441

More Related